Skip to content
OpenCapital
Get started

Iovance Biotherapeutics, Inc. IOVA Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

Century Communities logo
Century CommunitiesCCS
$22.22M+279%
EyePoint, Inc. logo
EyePoint, Inc. EYPT
$4.06M+16.7%
Equitable Holdings logo
Equitable HoldingsEQH
$371M-5.1%
Essential Utilities logo
Essential UtilitiesWTRG
-$75K+74.4%
Proto Labs logo
Proto LabsPRLB
$128.08M+5.2%
ICF International logo
ICF InternationalICFI
$660K-31.7%

Segments

By segment

See full
Single Reportable$8.25M-46.6%

Other financials

Income statement

See full
Revenue$71.4M+44.8%
Gross profit$28.9M+338%
Operating income-$81.0M+33.1%
Net income-$79.0M+32.0%
EPS (diluted)-$0.19+47.2%

Balance sheet

See full
Cash & equivalents$196.5M+14.5%
Total debt$46.8M-11.3%
Total equity$721.8M-6.0%
Total assets$925.7M-4.2%

Cash flow

See full
Operating cash flow-$72.1M+30.5%
CapEx$6.6M+6.4%
Free cash flow-$78.7M+28.4%

Valuation

See full
Market cap$1.9B+32.4%

Profitability

See full
Gross margin36.7%+4.1pp
Operating margin-127.2%-31.0pp
Net margin-123.9%-28.4pp
FCF margin-106.8%-27.5pp

Returns & leverage

See full
Return on equity-47.5%-3.7pp
Debt / equity0.1×0.0×
Current ratio3.6×-0.6×